Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clofarabine in Pediatric Refractory/Relapsed ALL
NCT00930098Phase 2Completed
- Sponsor
- Sanofi
- Start
- Dec 2003
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 6
01
Overview
A Phase 2 trial of clofarabine in acute lymphoblastic leukemia (ALL), sponsored by Sanofi. Started Dec 2003; status: completed.
02
Drugs
clofarabine
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00930098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00930098.